The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
出版年份 2017 全文链接
标题
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
作者
关键词
Non-small cell lung cancer, Immunohistochemistry techniques, Adenocarcinomas, Prognosis, Mutation, Squamous cell carcinomas, Surgical and invasive medical procedures, Surgical oncology
出版物
PLoS One
Volume 12, Issue 7, Pages e0181527
出版商
Public Library of Science (PLoS)
发表日期
2017-07-26
DOI
10.1371/journal.pone.0181527
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non–Small-Cell Lung Cancer: METLung
- (2017) David R. Spigel et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non–Small-Cell Lung Cancer
- (2016) In-Ho Kim et al. Clinical Lung Cancer
- Alterations of MET Gene Copy Number and Protein Expression in Primary Non–Small-Cell Lung Cancer and Corresponding Nodal Metastases
- (2016) Thang N. Tran et al. Clinical Lung Cancer
- Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature
- (2016) A.J. van der -->Wekken et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
- (2016) Mark M. Awad et al. JOURNAL OF CLINICAL ONCOLOGY
- Major Changes in Systemic Therapy for Advanced Melanoma
- (2016) John A. Thompson Journal of the National Comprehensive Cancer Network
- Identifying the Appropriate FISH Criteria for Defining MET Copy Number–Driven Lung Adenocarcinoma through Oncogene Overlap Analysis
- (2016) Sinéad A. Noonan et al. Journal of Thoracic Oncology
- Response to Crizotinib Observed in Lung Adenocarcinoma with MET Copy Number Gain but without a High-Level MET/CEP7 Ratio, MET Overexpression, or Exon 14 Splicing Mutations
- (2016) Yan Zhang et al. Journal of Thoracic Oncology
- EGFR mutation status on brain metastases from non-small cell lung cancer
- (2016) Fred Hsu et al. LUNG CANCER
- Application of the 2013 ASCO/CAP guideline and the SISH technique for HER2 testing of breast cancer selects more patients for anti-HER2 treatment
- (2016) António Polónia et al. VIRCHOWS ARCHIV
- Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?
- (2016) Witthawat Ariyawutyakorn et al. Journal of Cancer
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer
- (2015) Qiang Zhen et al. CYTOGENETIC AND GENOME RESEARCH
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Tumor MET Expression and Gene Amplification in Chinese Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
- (2015) Z. Peng et al. MOLECULAR CANCER THERAPEUTICS
- Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis
- (2015) Sabrina Rossi et al. Molecular Diagnosis & Therapy
- MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)
- (2015) David Casadevall et al. Oncotarget
- Prognostic Implications of Tumoral Expression of Insulin Like Growth Factors 1 and 2 in Patients With Non–Small-Cell Lung Cancer
- (2014) Jin-Soo Kim et al. Clinical Lung Cancer
- Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer
- (2014) M. Teresa Agulló-Ortuño et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study
- (2014) Antoni Ribas et al. LANCET ONCOLOGY
- Prognostic Value of MET Gene Copy Number and Protein Expression in Patients with Surgically Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Published Literatures
- (2014) Baoping Guo et al. PLoS One
- MET Gene Copy Number Predicts Worse Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC); A Systematic Review and Meta-Analysis
- (2014) Anastasios Dimou et al. PLoS One
- Ligand-independent activation of MET through IGF-1/IGF-1R signaling
- (2013) Andreas Varkaris et al. INTERNATIONAL JOURNAL OF CANCER
- Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
- (2013) David R. Spigel et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity
- (2013) R Castoldi et al. ONCOGENE
- Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2
- (2013) M. Acunzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study
- (2013) Christian Boch et al. BMJ Open
- c-Src Activation Mediates Erlotinib Resistance in Head and Neck Cancer by Stimulating c-Met
- (2012) L. P. Stabile et al. CLINICAL CANCER RESEARCH
- Clinical Significance of IGF1R Expression in Non–Small-Cell Lung Cancer
- (2012) Makoto Nakagawa et al. Clinical Lung Cancer
- Insulin-like growth factor-1 receptor protein expression and gene copy number alterations in non–small cell lung carcinomas
- (2012) Koji Tsuta et al. HUMAN PATHOLOGY
- Strain-Dependent Airway Hyperresponsiveness and a Chromosome 7 Locus of Elevated Lymphocyte Numbers in Cystic Fibrosis Transmembrane Conductance Regulator-Deficient Mice
- (2012) M. Bazett et al. JOURNAL OF IMMUNOLOGY
- Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer
- (2012) Rafal Dziadziuszko et al. Journal of Thoracic Oncology
- Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group
- (2012) Guénaëlle Levallet et al. Journal of Thoracic Oncology
- MET: a promising anticancer therapeutic target
- (2012) Solange Peters et al. Nature Reviews Clinical Oncology
- Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification
- (2011) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- c-MET/Phospho-MET Protein Expression and MET Gene Copy Number in Non-small Cell Lung Carcinomas
- (2011) Koji Tsuta et al. Journal of Thoracic Oncology
- HGF-independent potentiation of EGFR action by c-Met
- (2011) A M Dulak et al. ONCOGENE
- Detection of Hepatocyte Growth Factor (HGF) Ligand-c-MET Receptor Activation in Formalin-Fixed Paraffin Embedded Specimens by a Novel Proximity Assay
- (2011) Rajiv Dua et al. PLoS One
- The role of the c-Met pathway in lung cancer and the potential for targeted therapy
- (2011) Martin Sattler et al. Therapeutic Advances in Medical Oncology
- Molecular Diagnosis of Activating EGFR Mutations in Non-Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical Analysis
- (2010) A. Kawahara et al. CLINICAL CANCER RESEARCH
- Insulin-like Growth Factor Receptor 1 (IGF1R) Gene Copy Number Is Associated With Survival in Operable Non–Small-Cell Lung Cancer: A Comparison Between IGF1R Fluorescent In Situ Hybridization, Protein Expression, and mRNA Expression
- (2010) Rafal Dziadziuszko et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR
- (2010) Marie Brevet et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)
- (2010) Elaine H. Lim et al. Journal of Thoracic Oncology
- Clinical Significance of Epidermal Growth Factor Receptors in Non-small Cell Lung Cancer and a Prognostic Role for HER2 Gene Copy Number in Female Patients
- (2010) Samer Al-Saad et al. Journal of Thoracic Oncology
- High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer
- (2010) Heounjeong Go et al. Journal of Thoracic Oncology
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients
- (2009) F. Cappuzzo et al. ANNALS OF ONCOLOGY
- IncreasedMETGene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
- (2009) Federico Cappuzzo et al. JOURNAL OF CLINICAL ONCOLOGY
- MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve Cohort
- (2009) Michèle Beau-Faller et al. Journal of Thoracic Oncology
- The role of the insulin-like growth factor 1 receptor axis in multiple myeloma
- (2009) Eline Menu et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation